Showing results (11-20 of 125) with videos related to
Sort By:
Pageof 13
Journal of Neuroimmunology|October 13, 2007
Treating autoimmune demyelination by augmenting lymphocyte apoptosis in the central nervous systemMichael P PenderClinical & Translational Immunology|April 8, 2020
Hypothesis: bipolar disorder is an Epstein-Barr virus-driven chronic autoimmune disease - implications for immunotherapyMichael P PenderAutoimmunity Reviews|March 4, 2009
Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infectionMichael P PenderJournal of Autoimmunity|May 27, 2008
Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosisJudith M Greer, Michael P PenderCurrent Allergy and Asthma Reports|June 6, 2007
Immunology of multiple sclerosisMichael P Pender, Judith M GreerFrontiers in Immunology|August 13, 2013
Immune parameters to consider when choosing T-cell receptors for therapyScott R Burrows, John J MilesFrontiers in Immunology|September 25, 2020
Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA TypesJudith M Greer, Elisabeth Trifilieff, Michael P PenderFrontiers in Immunology|May 24, 2017
Reactivity to Novel Autoantigens in Patients with Coexisting Central Nervous System Demyelinating Disease and Autoimmune Thyroid DiseaseJudith M Greer, Simon Broadley, Michael P PenderTrends in Immunology|November 22, 2005
Have we cut ourselves too short in mapping CTL epitopes?Scott R Burrows, Jamie Rossjohn, James McCluskeyJournal of Neuroimmunology|April 4, 1998
The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitisCatherine A White, Pamela A McCombe, Michael P PenderPageof 13